Doctor Lili Xu
Zhongshan Hospital Fudan University, Shanghai (China)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Dapagliflozin decreases atherosclerotic plaque instability via regulating macrophage pyroptosis
Event: ESC Congress 2023
Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Session: Therapeutic strategies to combat vascular disease
Dapagliflozin decreases atherosclerotic plaque instability via regulating macrophage pyroptosis
Event: ESC Congress 2021 - The Digital Experience
Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Session: Congress committee e-posters choice in basic science
11-year follow-up outcomes of catheter ablation of para-hisian accessory pathways
Event: EHRA 2021
Topic: Catheter Ablation of Arrhythmias
Session: ePoster session
Histamine promotes atherosclerotic plaque instability via STAT6-dependent macrophage pyroptosis
Event: ESC Congress 2019
Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Session: Atherosclerosis and vascular dysfunction
Stat4 deficiency exacerbates atherosclerosis through promoting foam cell formation via pi3k/akt/nfkb/mir-9/acat1 pathway in ApoE-/- mice
Event: ESC Congress 2018
Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Session: Inflammation as a critical component of atherosclerosis
Histamine promotes the differentiation of macrophages from CD11b+ myeloid cells and formation of foam cells through a STAT6-dependent pathway
Event: ESC Congress 2017
Topic: Atherosclerosis
Session: Atherosclerosis
STAT4 deficiency exacerbates atherosclerosis by promoting mobilization of myeloid cells, polarization of M1 macrophages and formation of foam cells
Event: ESC Congress 2016
Topic: Atherosclerosis
Session: Therapeutic modulation of the immune response in atherosclerosis
ESC 365 is supported by
